Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$73.17 0.09 (0.12%) as of 4:30 Fri 4/26


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 104.63(B)
Last Volume: 8,786,292 Avg Vol: 8,469,733
52 Week Range: $48.64 - $73.26
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 86,763 367,796 891,893 1,852,495
Total Sell Value $5,815,387 $21,391,604 $49,075,093 $90,475,166
Total People Sold 6 8 11 13
Total Sell Transactions 9 19 36 69
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 1824
  Page 11 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-02-28 4 D $7.39 $8,417 D/D (1,139) 25,443     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-02-28 4 OE $0.00 $0 D/D 3,491 26,582     -
   Onuscheck John Michael SVP & President, EMEA   •       •      –    2013-02-28 4 D $7.39 $17,706 D/D (2,396) 71,830     -
   Onuscheck John Michael SVP & President, EMEA   •       •      –    2013-02-28 4 OE $0.00 $0 D/D 5,237 74,226     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-02-28 4 D $7.39 $10,405 D/D (1,408) 73,898     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-02-28 4 OE $0.00 $0 D/D 4,190 75,306     -
   Carruthers Wendy SVP, Human Resources   •       •      –    2013-02-27 4 D $7.33 $10,826 D/D (1,477) 42,277     -
   Carruthers Wendy SVP, Human Resources   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 4,617 43,754     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-02-27 4 D $7.33 $23,940 D/D (3,266) 91,406     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 9,952 94,672     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       •      –    2013-02-27 4 D $7.33 $20,934 D/D (2,856) 78,508     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 8,758 81,364     -
   Bose Supratim EVP & President, Asia-Pacific   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 3,184 18,109     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       •      –    2013-02-27 4 D $7.33 $7,843 D/D (1,070) 107,981     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 3,184 109,051     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-02-27 4 D $7.33 $43,760 D/D (5,970) 177,154     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 18,312 183,124     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       •      –    2013-02-27 4 D $7.33 $19,139 D/D (2,611) 84,192     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 7,961 86,803     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-02-27 4 D $7.33 $16,683 D/D (2,276) 23,091     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 7,165 25,367     -
   Mahoney Michael F President & CEO   •       •      –    2013-02-27 4 D $7.33 $136,734 D/D (18,654) 294,029     -
   Mahoney Michael F President & CEO   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 57,324 312,683     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       •      –    2013-02-27 4 D $7.33 $17,130 D/D (2,337) 74,852     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       •      –    2013-02-27 4 OE $0.00 $0 D/D 6,369 77,189     -
  1824 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 11 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us